GASTROINTESTINAL TUMORS
Clinical trials for GASTROINTESTINAL TUMORS explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL TUMORS trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radioactive therapy targets advanced tumors in early trial
Disease control Recruiting nowThis early-phase study tests a new radioactive drug called Lutetium BL-ARC001 in 22 adults with advanced gastrointestinal or other solid tumors that have spread. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. Participants must have …
Matched conditions: GASTROINTESTINAL TUMORS
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 11:28 UTC
-
New combo therapy aims to shrink hard-to-treat gut tumors
Disease control Recruiting nowThis study tests whether adding an experimental drug, KQB198, to the standard cancer drug imatinib is safe and works better for people with advanced gastrointestinal stromal tumor (GIST). About 46 adults with a specific gene mutation (KIT or PDGFRA) will receive the combination a…
Matched conditions: GASTROINTESTINAL TUMORS
Phase: PHASE2 • Sponsor: Kumquat Biosciences Inc. • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
New hope for advanced tumors: early trial of BL-M24D1 begins
Disease control Recruiting nowThis early-phase study tests a new drug, BL-M24D1, in people with advanced digestive tract or other solid tumors that have spread. The main goals are to check safety, find the right dose, and see if the drug shrinks tumors. About 33 adults will take part in this non-randomized tr…
Matched conditions: GASTROINTESTINAL TUMORS
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:53 UTC